Clinical Trial Update: Evaluation of Fluid Retention Due to Superpotent Topical Corticosteroid [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating fluid retention associated with a superpotent topical corticosteroid in bullous pemphigoid has completed. This update summariz…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bullous Pemphigoid

Drugs mentioned

• Superpotent topical corticosteroid

Snippet

Sponsor: University Hospital, Rouen | Conditions: Bullous Pemphigoid | Phase 4 | Status: COMPLETED